Vivera Pharmaceuticals Issues Statement Regarding LuSys Laboratories Covid-19 Tests
Vivera Pharmaceuticals is highly discouraged to read the latest FDA safety communication that erroneously lists Vivera Pharmaceuticals as a brand of LuSys Laboratories or as a distributor of the LuSys Eagle Diagnostics test. While Vivera did work with LuSys Laboratories in mid-2020, the scope of that engagement was limited to development of a United States […]
Vivera Pharmaceuticals Welcomes Shawn Ray to Ambassador Board
NEWPORT BEACH, Calif. – Vivera Pharmaceuticals, Inc., an innovative, science-driven pharmaceutical company, has welcomed Mr. Shawn Ray to the Company’s Ambassador Board. Mr. Ray will not only bring immense value through his expertise in health and fitness, but through his wide community reach, and valued insight into the wellness sector. During his competitive career, Mr. Ray […]
Vivera Pharmaceuticals and Burkhan Group Announce New COVID-19 Testing Initiative
NEWPORT BEACH, Calif., Jan. 25, 2021 /PRNewswire/ — Vivera Pharmaceuticals, in partnership with Burkhan Group, is excited to announce a new testing initiative in Southern California. Together, the two are paving the way for easier access to rapid testing as area businesses develop back to work protocols. With Vivera’s suite of lower cost COVID-19 testing, […]
Vivera Pharmaceuticals Announces $440 Million in Backing by JR Dallas Wealth Management
NEWPORT BEACH, Calif., Nov. 25, 2020 /PRNewswire/ — Vivera Pharmaceuticals and Burkhan World today announce financial backing by JR Dallas Wealth Management in support of Vivera’s global growth strategies. This ongoing partnership will provide financial services – including debt and equity backing – for the purchase and distribution of Vivera’s innovative testing and expansive medical […]
Vivera Pharmaceuticals Welcomes Gerald A. Maguire, MD to Advisory Board
NEWPORT BEACH, Calif., Nov. 24, 2020 /PRNewswire/ — Vivera Pharmaceuticals is pleased to announce the appointment of Dr. Gerald A. Maguire, Professor and Chair of Psychiatry and Neuroscience at the University of California, Riverside School of Medicine, to the Company’s advisory board as the Chief Advisor of Vivera’s new Neurosciences Division. As a world-renowned researcher […]
Vivera Pharmaceuticals Partners with EcoGroup USA in the Distribution of its BioZone Sanitizing Stations
NEWPORT BEACH, Calif., Nov. 18, 2020 /PRNewswire/ — Vivera Pharmaceuticals is excited to announce a distribution partnership with EcoGroup USA for Vivera’s BioZone, an advanced access control device intended for sanitization in high occupancy settings. BioZone is designed to combine facial recognition, integrated biometrics, and a hospital grade FDA and EPA approved organic sanitization mist […]
Vivera Pharmaceuticals Selected to Screen Travellers to the UAE for COVID-19
NEWPORT BEACH, Calif., Oct. 7, 2020 /PRNewswire/ — Vivera Pharmaceuticals has been selected by Pure Health, the largest laboratory network in the UAE, to test airline passengers flying into the United Arab Emirates in accordance with the UAE’s requirement for travelers to prove they are not infected with COVID-19. Pure Health has been appointed by […]
Vivera Pharmaceuticals announces Medical Technologies Division and BIOZONE Device
NEWPORT BEACH, Calif., Sept. 16, 2020 /PRNewswire/ — Vivera Pharmaceuticals, Inc. is pleased to announce the launch of BIOZONE, an innovative device designed for sanitization in high occupancy settings. Vivera’s BIOZONE device incorporates state of the art facial recognition, integrated biometrics, and a hospital grade organic sanitization mist. BIOZONE device in hospital corridor BIOZONE is […]
Vivera Pharmaceuticals Announces New Diagnostic Test Solution For COVID-19
Vivera has partnered with OmeCare, a leading provider of laboratory testing services NEWPORT BEACH, Calif., Sept. 9, 2020 /PRNewswire/ — Vivera Pharmaceuticals, Inc. is pleased to announce the launch of an exclusive partnership with OmeCare, a leading CLIA-certified global clinical laboratory provider. With results in less than 48 hours, the Vivera Pharmaceuticals + OmeCare rapid […]
Vivera Pharmaceuticals announces one-step COVID-19 testing cartridge
Clinical studies for COVID-19 antibody test use expected to start by October NEWPORT BEACH, Calif., Aug. 13, 2020 /PRNewswire/ — Vivera Pharmaceuticals, Inc. announced today the development of a new one-step testing cartridge for COVID-19 antibody testing. The ground-breaking cartridge will use a simplified procedure to help eliminate operator error and will lead to more […]
